$PGC

BABCOCK JOHN P sold $236K of PGC

BABCOCK JOHN P (SEVP & Pres of Priv Wealth Mgt) sold 5,000 shares of PEAPACK GLADSTONE FINANCIAL CORP (PGC) at $47.11 ($0.24M total) on 2026-06-29.

Original reporting
SEC EDGAR · BABCOCK JOHN P
Published Jun 30, 2026, 2:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 2:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PGC
Neutral
high confidence
Mentioned
$PGC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGCNeutralLow
01

Why it matters

This provides a fresh, primary-source datapoint on insider activity (5,000 shares sold), but it does not include any new operational or financial catalyst for PGC.

02

Market read

Traders may note insider selling activity, but the disclosure alone is unlikely to change valuation or near-term expectations materially.

03

What to watch

No 10b5-1 plan is cited; however, the article provides no context on prior sales, total insider exposure, or whether the sale was part of a broader pattern.

Relevance 4/10Novelty 3/10Timing: Filed 2026-06-30; sale executed 2026-06-29.

Background

The article is an SEC Form 4 insider transaction disclosure for PEAPACK GLADSTONE FINANCIAL CORP (PGC).

Company-level read

Ticker impact

$PGCNeutralHigh confidence
Context

SEC Form 4 shows insider John P. Babcock sold 5,000 shares of PGC on 2026-06-29 at $47.1065/share.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale.

Evidence & confidence

The filing is a disclosed transaction without accompanying new company-specific events (no guidance, deal, or regulatory action).

Market effects

No sector-level read-across; this is a single-insider transaction at a financial institution.

None indicated.

None indicated.

Counterpoint

The sale could reflect diversification/liquidity needs rather than bearish expectations, so it may not warrant any trading response.

Key entities

  • PEAPACK GLADSTONE FINANCIAL CORP

    Subject of the Form 4 insider transaction disclosure (PGC).

  • BABCOCK JOHN P

    SEVP & Pres of Private Wealth Management; reported open-market sale of PGC shares.

  • SEC Form 4

    Regulatory insider transaction report filed on EDGAR.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGCMed

PEAPACK GLADSTONE FINANCIAL CORP (PGC): REPORTS THIRD QUARTER FINANCIAL RESULTS

PEAPACK GLADSTONE FINANCIAL CORP (PGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Frank A. Cavallaro, SEVP and CFO Peapack-Gladstone Financial Corporation T: 908-306-8933 PEAPACK-GLADSTONE FINANCIAL CORPORATION REPORTS THIRD QUARTER FINANCIAL RESULTS Bedminster, N.J. – October 27, 2026 – Peapack-Gladstone Financial Corporation ( NASDAQ Gl

$PGCMed

PEAPACK GLADSTONE FINANCIAL CORP (PGC): REPORTS SECOND QUARTER FINANCIAL RESULTS

PEAPACK GLADSTONE FINANCIAL CORP (PGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pgc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Contact: Frank A. Cavallaro, SEVP and CFO Peapack-Gladstone Financial Corporation T: 908-306-8933 PEAPACK-GLADSTONE FINANCIAL CORPORATION REPORTS SECOND QUARTER FINANCIAL RESULTS Bedminster, N.J. – July 27, 2026 – Peapack-Glad

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).